A fast virtual screening approach to identify structurally diverse inhibitors of trypanothione reductase

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5255-8. doi: 10.1016/j.bmcl.2011.07.036. Epub 2011 Jul 19.

Abstract

Trypanothione reductase (TryR) is one of the favorite targets for those designing drugs for the treatment of Chagas disease. We present the application of a fast virtual screening approach for designing hit compounds active against TryR. Our protocol combines information derived from structurally known inhibitors and from the TryR receptor structure. Five structurally diverse hit compounds active against TryR and holding promise for the treatment of Chagas disease are reported.

MeSH terms

  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • High-Throughput Screening Assays*
  • Models, Molecular
  • Molecular Structure
  • NADH, NADPH Oxidoreductases / antagonists & inhibitors*
  • NADH, NADPH Oxidoreductases / metabolism
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • NADH, NADPH Oxidoreductases
  • trypanothione reductase